Syncope vs. Seizure: Ictal Bradycardia and Ictal Asystole.

Background: Ictal arrhythmia is a rare condition that causes arrhythmic manifestations induced by epileptic seizures, including asystole or bradycardia. Ictal asystole (IA) is a very rare condition found in patients undergoing video-encephalography (EEG) monitoring. It is often related to temporal lobe epilepsy and can cause syncope, which can lead to injury or even death. Case Presentation. Two patients with epilepsy showed symptoms of syncope. Both patients underwent 4-day ambulatory EEG tests and were diagnosed with IA. Following the tests, the patients were implanted with a permanent pacemaker, and one of them underwent a temporal lobectomy. As a result of these procedures, the patients experienced a reduction in episodes of symptomatic syncope. Conclusion: Patients with ictal asystole and symptomatic ictal bradycardia are at increased risk of falls due to seizures. Although there are no specific guidelines for managing this condition, antiseizure medications, epilepsy surgery, and cardiac pacemaker implantation have been effective treatments.

The long-term outcomes of patients with negative prolonged ambulatory electroencephalography tests: A cross-sectional follow-up study.

Background: Ambulatory electroencephalography (AEEG) recording is an essential aid for detecting interictal discharges and providing a clinical diagnosis. This study aimed to describe long-term outcomes among a cohort of patients who yielded negative results on AEEG at the time of assessment and identify factors associated with contemporary quality of life (QOL) and ultimate epilepsy diagnosis. Methods: This cross-sectional telephone follow-up study was conducted in June-November 2021 at the Neurology Department in a metropolitan hospital in Sydney, Australia. Results: In total, 47 of 105 eligible (45%) participants were enrolled. Overall, 21 (45%) participants had been diagnosed with epilepsy at a 12-year follow-up. Taking anti-seizure medication, having experienced a seizure event, and having marriage and education-related characteristics were associated with an epilepsy diagnosis. QOL was found to be associated with age, employment status and history of experience of a seizure event. QOL and an epilepsy diagnosis were not shown to be statistically related. Conclusions: Nearly half of the participants had received an epilepsy diagnosis at long-term follow-up, despite having tested negative on AEEG at the time of assessment. Prolonged AEEG testing is an important tool to aid the diagnostic process. However, clinical examination, including accurate history taking, is vital in establishing an epilepsy diagnosis.

Ambulatory electroencephalography (AEEG) recording is an essential aid for detecting interictal discharges and providing a clinical diagnosis. This study aimed to describe long-term outcomes among a cohort of patients who yielded negative results on AEEG at the time of assessment and identify factors associated with contemporary quality of life (QOL) and ultimate epilepsy diagnosis. This cross-sectional telephone follow-up study was conducted in June-November 2021 at the Neurology Department in a metropolitan hospital in Sydney, Australia. In total, 47 of 105 eligible (45%) participants were enrolled. Overall, 21 (45%) participants had been diagnosed with epilepsy at a 12-year follow-up. Taking anti-seizure medication, having experienced a seizure event, and having marriage and education-related characteristics were associated with an epilepsy diagnosis. QOL was found to be associated with age, employment status and history of experience of a seizure event. QOL and an epilepsy diagnosis were not shown to be statistically related. Nearly half of the participants had received an epilepsy diagnosis at long-term follow-up, despite having tested negative on AEEG at the time of assessment. Prolonged AEEG testing is an important tool to aid the diagnostic process. However, clinical examination, including accurate history taking, is vital in establishing an epilepsy diagnosis.

A Prospective Randomized Controlled Trial: Alternative Approach to EEG Application to Reduce Electrode-induced Skin Injury among Ambulatory EEG Patients.

Ambulatory electroencephalography (AEEG) is a technique of continuous EEG recording of patients in their natural setting, outside the controlled environment of the hospital. Electrode-induced skin injury is a common complication of prolonged EEG monitoring. This randomized study aimed to investigate the performance of two methods of electrode application in reducing electrode-induced skin injury among patients undergoing 4-day AEEG monitoring. A randomized interventional study was conducted from November 2020 to May 2021 in the Neurosciences Ambulatory Care Unit at a metropolitan hospital in Sydney, Australia. We enrolled patients into two groups: i) Group 1 (standard protocol group) received Ten20 Conductive PasteTM with Tensive® adhesive gel as the primary approach to electrode application and ii) Group 2 (intervention group) received Ten20 Conductive PasteTM with Tensive® adhesive gel and hydrogel electrodes on hairless locations as the primary approach to electrode application. A total of 79 patients participated in this study. The group that received the addition of hydrogel electrodes (Group 2) performed better than the standard protocol group on electrode site inflammation for the frontal region, particularly FP1, FP2, F8, and the ground electrode sites. EEG quality and self-reports of patient comfort and mood did not differ significantly between the two groups. The addition of hydrogel electrodes using a Ten20 Conductive PasteTM with a Tensive® adhesive gel protocol results in reduced inflammation at frontal lobe and ground electrode sites.

Implementation of a New Clinical Testing Tool to Assess Patients During Ictal and Postictal Periods.

ABSTRACT: BACKGROUND: A seizure is a sudden, uncontrolled electrical disturbance of the cortical neurons in the brain, which can cause changes in behavior, movements, feelings, and consciousness. Clinical signs and symptoms before, during, and after a seizure can help to determine the seizure onset. The use of standardized clinical testing tools has been reported as being valuable, although also challenging, by some institutions. This study investigated the effectiveness of implementing a new clinical testing tool designed with an emphasis on simplicity for use during and after seizures. METHODS: A pre-and-post evaluation study was conducted from January 2020 to November 2020 in the epilepsy monitoring unit/neurology unit at a hospital in Sydney, Australia. The primary outcome of interest was the incidence of clinical testing during seizures. The secondary outcome of interest was nurse knowledge about clinical testing during a seizure. This knowledge was measured via testing before and after clinical education sessions. The third outcome of interest was nurse confidence regarding the use of the clinical testing tool. The confidence level was measured via posteducation session follow-up surveying. RESULTS: Forty-seven nursing staff (10 neurophysiology nurse technologists and 37 neurology unit nurses) participated in the education program. Forty-four seizures were evaluated. Clinical testing during ictal and postictal periods was performed by nursing staff 82% of the time during 2020, compared with 67% during the 2018 to 2019 preeducation comparison period. This difference was not statistically significant, but it was clinically relevant (P = .07). In addition, the time from seizure alarm to clinical testing improved significantly from a median of 30.5 seconds in 2018 to 2019 to 14 seconds in 2020 (P < .001). CONCLUSION: The tool is easy and convenient for nursing staff to perform clinical examinations accurately during ictal and postictal periods.

Reducing EEG (Electroencephalogram) Electrode-induced Skin Injury among Ambulatory EEG Monitored Patients: A Non-randomized Interventional Study of Two Commonly Used Cream-based Products for Electrode Application.

Ambulatory electroencephalography (AEEG) seeks to capture inter-ictal epileptiform activity or paroxysmal events when patients are not in the clinic. Skin inflammation is a common complication of prolonged EEG monitoring. This non-randomized study aimed to investigate the performance of two commonly used cream-based methods of electrode application in reducing electrode-induced skin injury among patients undergoing AEEG monitoring. A non-randomized interventional study was conducted from July to December 2019 in the Neurosciences Ambulatory Care Unit at Royal Prince Alfred Hospital, Australia. Patients were enrolled into two groups: i) Group T, which received Ten20® Conductive Paste with Tensive® Conductive Adhesive Gel as the primary approach to electrode application; ii). Group E, which received EC2⁺® Conductive Cream as the primary approach to electrode application. Patients in Group T were enrolled in the 1st and 3rd week of the month, and patients in Group E were enrolled in the 2nd and 4th week for each month of the study. A total of 152 patients participated in this study. Two sub-groups were established: those who were monitored for two days (Group T; n = 36, Group E; n = 30) and those who were monitored for four days (Group T; n = 43, Group E; n = 43). Significant (p < 0.05) differences indicating greater inflammation in the Group E were noted for both Day 2 and Day 4 participants. Skin injury/inflammation was significantly less using the standard method (Group T: Ten20® with Tensive® gel) when compared to EC2⁺® (Group E) as the conductive material at the electrode site.

EEG Electrode-induced Skin Injury among Adult Patients Undergoing Ambulatory EEG Monitoring.

Introduction: Ambulatory electroencephalography technology has improved in the last 40 years. Many clinicians believe that some skin injury is an unavoidable complication of prolonged EEG monitoring. In this study, we examined potential risk factors associated with electrode-induced skin injury in adult patients with AEEG monitoring. Methods: A cross-sectional observational study was conducted from December 2017 to October 2018, in the outpatient clinic at a teaching hospital in Sydney, Australia. Patients were included if they were older than 16 years of age and had been referred for AEEG monitoring of two to five days duration. Trained neurophysiology nurses completed a pre-application skin assessment before they applied the EEG electrodes. Daily assessments of the skin condition were conducted. The patients completed a questionnaire to assess comfort levels at the completion of the testing. Results: A total of 251 patients participated in this study. Two groups were established - those who were monitored for 2-3 days (Group 1; n = 92) and those who were monitored for 4-5 days (Group 2; n = 159). There was a significant acceleration in inflammation which occurred between day 2 and day 4/5. Cross-sectional analyses of patient characteristics showed that increasing age, fair skin color, dry skin texture and fine hair texture were the prevailing risk factors for greater inflammation scores. Conclusion: The patient discomfort and inflammatory burden associated with this procedure were high. Inflammation was shown to increase with the duration of electrode application.